CAR-T efficacy: Is conditioning the key?

Sattva S. Neelapu

doi:10.1182/blood-2019-03-900928

CAR-T efficacy: Is conditioning the key?

Sattva S. Neelapu

Lymphoma-Myeloma

Research output: Contribution to journal › Review article › peer-review

73 Scopus citations

Abstract

In this issue of Blood, Hirayama and colleagues report that a favorable cytokine profile induced by lymphodepletion is associated with durable remissions in patients with aggressive non-Hodgkin lymphoma treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.

Original language	English (US)
Pages (from-to)	1799-1800
Number of pages	2
Journal	Blood
Volume	133
Issue number	17
DOIs	https://doi.org/10.1182/blood-2019-03-900928
State	Published - Apr 25 2019

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2019-03-900928

Cite this

@article{9792050e62604aa59ce77d0315d27594,

title = "CAR-T efficacy: Is conditioning the key?",

abstract = "In this issue of Blood, Hirayama and colleagues report that a favorable cytokine profile induced by lymphodepletion is associated with durable remissions in patients with aggressive non-Hodgkin lymphoma treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.",

author = "Neelapu, {Sattva S.}",

note = "Publisher Copyright: {\textcopyright} 2019 by The American Society of Hematology",

year = "2019",

month = apr,

day = "25",

doi = "10.1182/blood-2019-03-900928",

language = "English (US)",

volume = "133",

pages = "1799--1800",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "17",

}

TY - JOUR

T1 - CAR-T efficacy

T2 - Is conditioning the key?

AU - Neelapu, Sattva S.

PY - 2019/4/25

Y1 - 2019/4/25

N2 - In this issue of Blood, Hirayama and colleagues report that a favorable cytokine profile induced by lymphodepletion is associated with durable remissions in patients with aggressive non-Hodgkin lymphoma treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.

AB - In this issue of Blood, Hirayama and colleagues report that a favorable cytokine profile induced by lymphodepletion is associated with durable remissions in patients with aggressive non-Hodgkin lymphoma treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.

UR - http://www.scopus.com/inward/record.url?scp=85065305652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065305652&partnerID=8YFLogxK

U2 - 10.1182/blood-2019-03-900928

DO - 10.1182/blood-2019-03-900928

M3 - Review article

C2 - 31023743

AN - SCOPUS:85065305652

SN - 0006-4971

VL - 133

SP - 1799

EP - 1800

JO - Blood

JF - Blood

IS - 17

ER -

CAR-T efficacy: Is conditioning the key?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this